| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atyr Pharma Inc (ATYR) has 4 insiders with recent SEC Form 4 filings, including 11 buys and 1 sell. ATYR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.50M | $1.39M | - | |
| Dir | 1.41M | $1.31M | - | |
| CFO | 412.5K | $382.1K | - | |
| Other | 412.5K | $382.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2023 | Shukla Sanjay66 | President And CEO | Buy | 15,000 | $1.18 | $17,646.00 | +8.1% | +34.5% | +166.4% | |
| Nov 13, 2023 | Shukla Sanjay66 | President And CEO | Buy | 15,000 | $1.11 | $16,703.39 | +9.8% | +76.7% | +213.0% | |
| Jul 28, 2023 | Shukla Sanjay66 | President And CEO | Buy | 15,000 | $2.01 | $30,223.50 | +24.5% | -38.8% | +10.4% | |
| May 10, 2023 | Schimmel Paul53 | Director | Buy | 200,000 | $2.25 | $450,000.00 | +177.0% | -13.3% | -23.9% | |
| Feb 6, 2023 | Broadfoot Jill Marie61 | Chief Financial Officer | Sale+OE | 1,566 | $2.36 | $3,695.76 | -9.2% | -12.7% | -32.7% | |
| Nov 21, 2022 | Shukla Sanjay66 | President And CEO | Buy | 10,000 | $2.14 | $21,405.00 | +24.5% | +1.9% | -46.5% | |
| Jul 1, 2022 | Shukla Sanjay66 | President And CEO | Buy | 15,000 | $2.88 | $43,164.00 | +58.1% | 0.0% | -24.2% | |
| Jan 13, 2022 | Broadfoot Jill Marie61 | Chief Financial Officer | Buy | 1,923 | $6.75 | $12,980.25 | +18.9% | -23.9% | -65.3% | |
| Jan 7, 2022 | Shukla Sanjay66 | President And CEO | Buy | 5,000 | $6.76 | $33,806.50 | +24.0% | -22.5% | -63.0% | |
| Nov 15, 2021 | Shukla Sanjay66 | President And CEO | Buy | 2,500 | $8.58 | $21,437.50 | +13.7% | -40.1% | -71.3% |